RNF13-related severe early-onset epileptic encephalopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:544503OMIM:618379G40.4
Who is this for?
Show terms as
8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

RestlessnessHP:0000711EEG with generalized slow activityHP:0010845EEG with focal epileptiform dischargesHP:0011185
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2022

Ztalmy: FDA approved

Treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for RNF13-related severe early-onset epileptic encephalopathy.

View clinical trials →

No actively recruiting trials found for RNF13-related severe early-onset epileptic encephalopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the RNF13-related severe early-onset epileptic encephalopathy community →

No specialists are currently listed for RNF13-related severe early-onset epileptic encephalopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

Ztalmy

Marinus Pharmaceuticals

Ztalmy — Contact Marinus Pharmaceuticals

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to RNF13-related severe early-onset epileptic encephalopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open RNF13-related severe early-onset epileptic encephalopathyForum →

No community posts yet. Be the first to share your experience with RNF13-related severe early-onset epileptic encephalopathy.

Start the conversation →

Latest news about RNF13-related severe early-onset epileptic encephalopathy

No recent news articles for RNF13-related severe early-onset epileptic encephalopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about RNF13-related severe early-onset epileptic encephalopathy

What treatment and support options exist for RNF13-related severe early-onset epileptic encephalopathy?

1 patient support program are currently tracked on UniteRare for RNF13-related severe early-onset epileptic encephalopathy. See the treatments and support programs sections for copay assistance, eligibility, and contact details.